NVS Jan 2024 70.000 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

2.5000

0.0000

(0.00%)

As of 11:15AM EDT. Market open.

Zacks
Q2 Earnings Season Preview and Featured Analyst Reports for J&J, AMD & Union Pacific
Today's Research Daily features preview of the Q2 earnings season and new research reports for J&J (JNJ), AMD (AMD), and Union Pacific (UNP).
Zacks
Novartis (NVS) Gets Positive CHMP Opinion for Scemblix in CML
The CHMP recommends approval of Novartis' (NVS) Scemblix for treating adult patients with chronic myeloid leukemia. EU also approves label expansion of Cosentyx.
Zacks
Pharma Stock Roundup: FDA OK's Expanded Use of ABBV, MRK, NVS Drugs, Other Updates
The FDA approves expanded use of AbbVie's (ABBV) Skyrizi, Merck's (MRK) Vaxneuvance vaccine and Novartis's (NVS) cancer combination drugs, Tafinlar (dabrafenib) + Mekinist (trametinib).